Elevate your approach to regenerative health with personalized peptide therapy. Explore treatment options that may support recovery, body composition, metabolic health, and healthy aging.
Elevate your approach to regenerative health with personalized peptide therapy. Explore treatment options that may support recovery, body composition, metabolic health, and healthy aging.
Elevate your approach to regenerative health with personalized peptide therapy. Explore treatment options that may support recovery, body composition, metabolic health, and healthy aging.
The term peptide therapy can refer to a wide range of different amino acid chains that interact with different biological pathways. These compounded sequences vary significantly in their mechanisms, clinical evidence, regulatory status, and potential applications.
Some peptide-based medications have undergone FDA review and are approved for specific medical conditions. Other peptides remain investigational or have limited human clinical evidence.

With more than a decade of experience in regenerative medicine, BiogenesisRx brings a comprehensive, evidence-informed approach to personalized peptide therapy. Our telehealth providers consider the available scientific evidence, your health profile, the specific therapy being considered, and applicable regulatory requirements before determining whether treatment may be appropriate.
Our goal isn't to follow the latest peptide trend. It's to help you understand your options and determine what, if anything, makes sense for your individual health plan.
Depending on your individual health needs and clinical evaluation, peptide-based treatments may be considered in the context of:

Personalized goals related to metabolism, glucose regulation, and body composition.

Recovery and physical wellness goals as part of a broader health and lifestyle plan.

Long-term health and wellness goals, informed by your individual health profile and available evidence.

Broader goals related to physical wellness, function, and healthy aging.
The appropriate treatment, if any, depends on the individual—not simply on a particular symptom or goal.
The term peptide therapy can refer to a wide range of different amino acid chains that interact with different biological pathways. These compounded sequences vary significantly in their mechanisms, clinical evidence, regulatory status, and potential applications.
Some peptide-based medications have undergone FDA review and are approved for specific medical conditions. Other peptides remain investigational or have limited human clinical evidence.

With more than a decade of experience in regenerative medicine, BiogenesisRx brings a comprehensive, evidence-informed approach to personalized peptide therapy. Our telehealth providers consider the available scientific evidence, your health profile, the specific therapy being considered, and applicable regulatory requirements before determining whether treatment may be appropriate.
Our goal isn't to follow the latest peptide trend. It's to help you understand your options and determine what, if anything, makes sense for your individual health plan.
Depending on your individual health needs and clinical evaluation, peptide-based treatments may be considered in the context of:

Personalized goals related to metabolism, glucose regulation, and body composition.

Recovery and physical wellness goals as part of a broader health and lifestyle plan.

Long-term health and wellness goals, informed by your individual health profile and available evidence.

Broader goals related to physical wellness, function, and healthy aging.
The appropriate treatment, if any, depends on the individual—not simply on a particular symptom or goal.
The term peptide therapy can refer to a wide range of different amino acid chains that interact with different biological pathways. These compounded sequences vary significantly in their mechanisms, clinical evidence, regulatory status, and potential applications.
Some peptide-based medications have undergone FDA review and are approved for specific medical conditions. Other peptides remain investigational or have limited human clinical evidence.

With more than a decade of experience in regenerative medicine, BiogenesisRx brings a comprehensive, evidence-informed approach to personalized peptide therapy. Our providers consider the available scientific evidence, your health profile, the specific therapy being considered, and applicable regulatory requirements before determining whether treatment may be appropriate.
Our goal isn't to follow the latest peptide trend. It's to help you understand your options and determine what, if anything, makes sense for your individual health plan.
Depending on your individual health needs and clinical evaluation, peptide-based treatments may be considered in the context of:

Personalized goals related to metabolism, glucose regulation, and body composition.

Recovery and physical wellness goals as part of a broader health and lifestyle plan.

Long-term health and wellness goals, informed by your individual health profile and available evidence.

Broader goals related to physical wellness, function, and healthy aging.
The appropriate treatment, if any, depends on the individual—not simply on a particular symptom or goal.

Some peptide-based medications have undergone FDA review and are approved for specific medical conditions.
For example, certain GLP-1–based and related medications have been FDA-approved for specific indications involving metabolic health, type 2 diabetes, and weight management. FDA approval applies to the specific medication, formulation, and indication reviewed by the agency.
Your provider can discuss FDA-approved treatment options that may be appropriate for your individual circumstances.
Important: FDA approval of a medication does not mean that every formulation or compounded version of that medication is FDA-approved. Compounded drugs are not FDA-approved.
Some peptide-based medications have undergone FDA review and are approved for specific medical conditions.
For example, certain GLP-1–based and related medications have been FDA-approved for specific indications involving metabolic health, type 2 diabetes, and weight management. FDA approval applies to the specific medication, formulation, and indication reviewed by the agency.
Your provider can discuss FDA-approved treatment options that may be appropriate for your individual circumstances.
Important: FDA approval of a medication does not mean that every formulation or compounded version of that medication is FDA-approved. Compounded drugs are not FDA-approved.


Some peptide-based medications have undergone FDA review and are approved for specific medical conditions.
For example, certain GLP-1–based and related medications have been FDA-approved for specific indications involving metabolic health, type 2 diabetes, and weight management. FDA approval applies to the specific medication, formulation, and indication reviewed by the agency.
Your provider can discuss FDA-approved treatment options that may be appropriate for your individual circumstances.
Important: FDA approval of a medication does not mean that every formulation or compounded version of that medication is FDA-approved. Compounded drugs are not FDA-approved.
Peptide research continues to explore how different compounds interact with biological pathways. The compounds below are included to provide educational context about areas of ongoing research.
The inclusion of a compound on this page does not mean that it is FDA-approved, that it is appropriate for every patient, or that BiogenesisRx recommends or prescribes it. Regulatory status, available evidence, and clinical appropriateness vary by compound.

Semax and Selank have been investigated in research involving neurological signaling, cognitive processes, and stress-related pathways. Evidence regarding their potential clinical applications remains limited, and additional research is needed.
FDA has identified safety and characterization concerns for compounded products containing Semax and Selank acetate, including potential risks related to peptide impurities and immunogenicity

BPC-157 has been investigated primarily in preclinical research involving processes related to tissue repair and other biological functions. Human clinical evidence remains limited.
TB-500 has also been investigated in preclinical and laboratory research. FDA materials note that no studies were identified in which TB-500 was administered to humans in the research reviewed by the agency.
These compounds should not be presented as established treatments based solely on preclinical findings.

Epitalon has been investigated in research involving biological processes associated with aging and cellular function.
However, research interest does not establish clinical effectiveness. FDA has identified potential safety concerns associated with compounded epitalon, including potential risks related to immunogenicity and peptide-related impurities.

CJC-1295 and Ipamorelin have been studied for their effects on growth hormone signaling and related physiological processes.
Research involving these compounds continues to evolve, and evidence and regulatory considerations vary by compound, formulation, and intended use. FDA has evaluated nominated bulk substances such as CJC-1295 and ipamorelin in the context of its compounding review process; such evaluation does not constitute FDA approval of a drug product or treatment.

A compound being studied in laboratory, animal, or human research does not mean that it has been FDA-approved or established as safe and effective for a particular medical use.
Some compounds discussed in peptide research may have limited human data or may raise unresolved safety or compounding considerations. Treatment decisions should therefore be based on an individualized medical evaluation and the evidence and regulatory information available at the time of care.
Peptide research continues to explore how different compounds interact with biological pathways. The compounds below are included to provide educational context about areas of ongoing research.
The inclusion of a compound on this page does not mean that it is FDA-approved, that it is appropriate for every patient, or that BiogenesisRx recommends or prescribes it. Regulatory status, available evidence, and clinical appropriateness vary by compound.

Semax and Selank have been investigated in research involving neurological signaling, cognitive processes, and stress-related pathways. Evidence regarding their potential clinical applications remains limited, and additional research is needed.
FDA has identified safety and characterization concerns for compounded products containing Semax and Selank acetate, including potential risks related to peptide impurities and immunogenicity

BPC-157 has been investigated primarily in preclinical research involving processes related to tissue repair and other biological functions. Human clinical evidence remains limited.
TB-500 has also been investigated in preclinical and laboratory research. FDA materials note that no studies were identified in which TB-500 was administered to humans in the research reviewed by the agency.
These compounds should not be presented as established treatments based solely on preclinical findings.

Epitalon has been investigated in research involving biological processes associated with aging and cellular function.
However, research interest does not establish clinical effectiveness. FDA has identified potential safety concerns associated with compounded epitalon, including potential risks related to immunogenicity and peptide-related impurities.

CJC-1295 and Ipamorelin have been studied for their effects on growth hormone signaling and related physiological processes.
Research involving these compounds continues to evolve, and evidence and regulatory considerations vary by compound, formulation, and intended use. FDA has evaluated nominated bulk substances such as CJC-1295 and ipamorelin in the context of its compounding review process; such evaluation does not constitute FDA approval of a drug product or treatment.

A compound being studied in laboratory, animal, or human research does not mean that it has been FDA-approved or established as safe and effective for a particular medical use.
Some compounds discussed in peptide research may have limited human data or may raise unresolved safety or compounding considerations. Treatment decisions should therefore be based on an individualized medical evaluation and the evidence and regulatory information available at the time of care.
Peptide research continues to explore how different compounds interact with biological pathways. The compounds below are included to provide educational context about areas of ongoing research.
The inclusion of a compound on this page does not mean that it is FDA-approved, that it is appropriate for every patient, or that BiogenesisRx recommends or prescribes it. Regulatory status, available evidence, and clinical appropriateness vary by compound.

Semax and Selank have been investigated in research involving neurological signaling, cognitive processes, and stress-related pathways. Evidence regarding their potential clinical applications remains limited, and additional research is needed.
FDA has identified safety and characterization concerns for compounded products containing Semax and Selank acetate, including potential risks related to peptide impurities and immunogenicity

BPC-157 has been investigated primarily in preclinical research involving processes related to tissue repair and other biological functions. Human clinical evidence remains limited.
TB-500 has also been investigated in preclinical and laboratory research. FDA materials note that no studies were identified in which TB-500 was administered to humans in the research reviewed by the agency.
These compounds should not be presented as established treatments based solely on preclinical findings.

Epitalon has been investigated in research involving biological processes associated with aging and cellular function.
However, research interest does not establish clinical effectiveness. FDA has identified potential safety concerns associated with compounded epitalon, including potential risks related to immunogenicity and peptide-related impurities.

CJC-1295 and Ipamorelin have been studied for their effects on growth hormone signaling and related physiological processes.
Research involving these compounds continues to evolve, and evidence and regulatory considerations vary by compound, formulation, and intended use. FDA has evaluated nominated bulk substances such as CJC-1295 and ipamorelin in the context of its compounding review process; such evaluation does not constitute FDA approval of a drug product or treatment.

A compound being studied in laboratory, animal, or human research does not mean that it has been FDA-approved or established as safe and effective for a particular medical use.
Some compounds discussed in peptide research may have limited human data or may raise unresolved safety or compounding considerations. Treatment decisions should therefore be based on an individualized medical evaluation and the evidence and regulatory information available at the time of care.
Your provider considers your individual health profile, goals, medical history, and needs before determining whether a treatment may be appropriate.
BiogenesisRx is a healthcare practice, not a drug manufacturer or pharmacy.
When a prescription is medically appropriate, it may be dispensed by one of our trusted licensed pharmacies in accordance with applicable federal and state requirements. The dispensing pharmacy is responsible for the preparation and dispensing of the medication.
We prioritize transparency regarding pharmacy sourcing and quality documentation when appropriate. A peptide Certificate of Analysis (COA) is a laboratory report that confirms a specific batch of a peptide's molecular identity and purity and can be requested at any time.
Important: FDA does not approve or license pharmacies or outsourcing facilities as "FDA-approved pharmacies." Compounded medications themselves are not FDA-approved.
Patient safety is central to our approach. Your provider considers potential benefits, risks, alternatives, and available evidence when discussing treatment options.
Relevant laboratory testing may help provide a more complete picture of your health and may inform treatment decisions when clinically appropriate.
You work directly with a provider who takes the time to understand your goals, answer your questions, monitor your progress, and adjust your plan when clinically appropriate.
We don't believe in choosing a peptide simply because it is popular or trending. Treatment decisions are made in the context of your individual health plan.


Discuss your health goals, concerns, medical history, and what you are hoping to accomplish with one of our expert clinicians.

Your assigned provider reviews your health history and may recommend laboratory testing or other evaluation based on your individual circumstances.

If treatment is medically appropriate, your provider will discuss relevant options, including the available evidence, potential benefits and risks, and applicable regulatory considerations.

If a prescription is appropriate, your provider will establish an individualized treatment plan.

Prescribed medication is dispensed by the applicable pharmacy. Your provider can continue to monitor your progress and make adjustments when clinically appropriate.
Peptide-based treatments are not appropriate for everyone. Your provider will determine whether a particular treatment may be appropriate based on your individual health profile, medical needs, available evidence, and applicable requirements.
No. Peptide-based medications have different regulatory statuses. Some have undergone FDA review and are approved for specific medical conditions. Other compounds remain investigational or have limited clinical evidence.
FDA approval applies to a specific medication for specific approved uses. It does not mean that every formulation, compounded version, or use of a related compound has been FDA-approved.
Compounding involves preparing a medication to meet the needs of an individual patient when certain conditions are met under applicable law.
Compounded medications are not FDA-approved, which means FDA does not review them for safety, effectiveness, or quality before they are marketed. Compounding may be appropriate in certain circumstances when an FDA-approved medication does not meet an individual patient's medical needs.
Not necessarily. The peptides discussed on this page include compounds at different stages of scientific and regulatory evaluation. A compound being discussed for educational purposes does not mean that it is FDA-approved, available for prescription, or appropriate for an individual patient.
Your provider will determine what treatment options, if any, are medically appropriate.
Your provider may recommend laboratory testing as part of your evaluation. The specific testing depends on your individual health needs and the treatment being considered.
Depending on your individual needs and clinical evaluation, treatment may be incorporated into a broader personalized health plan that can include nutrition, lifestyle recommendations, hormone care, weight management, or other appropriate services.
The first step is a consultation with a BiogenesisRx provider. Together, you'll discuss your goals, review your health history, and determine whether a peptide-based treatment or another approach may be appropriate for you.
Your provider considers your individual health profile, goals, medical history, and needs before determining whether a treatment may be appropriate.
BiogenesisRx is a healthcare practice, not a drug manufacturer or pharmacy.
When a prescription is medically appropriate, it may be dispensed by one of our trusted licensed pharmacies in accordance with applicable federal and state requirements. The dispensing pharmacy is responsible for the preparation and dispensing of the medication.
We prioritize transparency regarding pharmacy sourcing and quality documentation when appropriate. A peptide Certificate of Analysis (COA) is a laboratory report that confirms a specific batch of a peptide's molecular identity and purity and can be requested at any time.
Important: FDA does not approve or license pharmacies or outsourcing facilities as "FDA-approved pharmacies." Compounded medications themselves are not FDA-approved.
Patient safety is central to our approach. Your provider considers potential benefits, risks, alternatives, and available evidence when discussing treatment options.
Relevant laboratory testing may help provide a more complete picture of your health and may inform treatment decisions when clinically appropriate.
We don't believe in choosing a peptide simply because it is popular or trending. Treatment decisions are made in the context of your individual health plan.


Discuss your health goals, concerns, medical history, and what you are hoping to accomplish with one of our expert clinicians.

Your assigned provider reviews your health history and may recommend laboratory testing or other evaluation based on your individual circumstances.

If treatment is medically appropriate, your provider will discuss relevant options, including the available evidence, potential benefits and risks, and applicable regulatory considerations.

If a prescription is appropriate, your provider will establish an individualized treatment plan.

Prescribed medication is dispensed by the applicable pharmacy. Your provider can continue to monitor your progress and make adjustments when clinically appropriate.
Peptide-based treatments are not appropriate for everyone. Your provider will determine whether a particular treatment may be appropriate based on your individual health profile, medical needs, available evidence, and applicable requirements.
No. Peptide-based medications have different regulatory statuses. Some have undergone FDA review and are approved for specific medical conditions. Other compounds remain investigational or have limited clinical evidence.
FDA approval applies to a specific medication for specific approved uses. It does not mean that every formulation, compounded version, or use of a related compound has been FDA-approved.
Compounding involves preparing a medication to meet the needs of an individual patient when certain conditions are met under applicable law.
Compounded medications are not FDA-approved, which means FDA does not review them for safety, effectiveness, or quality before they are marketed. Compounding may be appropriate in certain circumstances when an FDA-approved medication does not meet an individual patient's medical needs.
Not necessarily. The peptides discussed on this page include compounds at different stages of scientific and regulatory evaluation. A compound being discussed for educational purposes does not mean that it is FDA-approved, available for prescription, or appropriate for an individual patient.
Your provider will determine what treatment options, if any, are medically appropriate.
Your provider may recommend laboratory testing as part of your evaluation. The specific testing depends on your individual health needs and the treatment being considered.
Depending on your individual needs and clinical evaluation, treatment may be incorporated into a broader personalized health plan that can include nutrition, lifestyle recommendations, hormone care, weight management, or other appropriate services.
The first step is a consultation with a BiogenesisRx provider. Together, you'll discuss your goals, review your health history, and determine whether a peptide-based treatment or another approach may be appropriate for you.
Your provider considers your individual health profile, goals, medical history, and needs before determining whether a treatment may be appropriate.
Patient safety is central to our approach. Your provider considers potential benefits, risks, alternatives, and available evidence when discussing treatment options.
Relevant laboratory testing may help provide a more complete picture of your health and may inform treatment decisions when clinically appropriate.
You work directly with a provider who takes the time to understand your goals, answer your questions, monitor your progress, and adjust your plan when clinically appropriate.
We don't believe in choosing a peptide simply because it is popular or trending. Treatment decisions are made in the context of your individual health plan.
BiogenesisRx is a healthcare practice, not a drug manufacturer or pharmacy.
When a prescription is medically appropriate, it may be dispensed by one of our trusted licensed pharmacies in accordance with applicable federal and state requirements. The dispensing pharmacy is responsible for the preparation and dispensing of the medication.
We prioritize transparency regarding pharmacy sourcing and quality documentation when appropriate. A peptide Certificate of Analysis (COA) is a laboratory report that confirms a specific batch of a peptide's molecular identity and purity and can be requested at any time.
Important: FDA does not approve or license pharmacies or outsourcing facilities as "FDA-approved pharmacies." Compounded medications themselves are not FDA-approved.


Discuss your health goals, concerns, medical history, and what you are hoping to accomplish with one of our expert clinicians.

Your assigned provider reviews your health history and may recommend laboratory testing or other evaluation based on your individual circumstances.

If treatment is medically appropriate, your provider will discuss relevant options, including the available evidence, potential benefits and risks, and applicable regulatory considerations.

If a prescription is appropriate, your provider will establish an individualized treatment plan.

Prescribed medication is dispensed by the applicable pharmacy. Your provider can continue to monitor your progress and make adjustments when clinically appropriate.
Peptide-based treatments are not appropriate for everyone. Your provider will determine whether a particular treatment may be appropriate based on your individual health profile, medical needs, available evidence, and applicable requirements.
No. Peptide-based medications have different regulatory statuses. Some have undergone FDA review and are approved for specific medical conditions. Other compounds remain investigational or have limited clinical evidence.
FDA approval applies to a specific medication for specific approved uses. It does not mean that every formulation, compounded version, or use of a related compound has been FDA-approved.
Compounding involves preparing a medication to meet the needs of an individual patient when certain conditions are met under applicable law.
Compounded medications are not FDA-approved, which means FDA does not review them for safety, effectiveness, or quality before they are marketed. Compounding may be appropriate in certain circumstances when an FDA-approved medication does not meet an individual patient's medical needs.
Not necessarily. The peptides discussed on this page include compounds at different stages of scientific and regulatory evaluation. A compound being discussed for educational purposes does not mean that it is FDA-approved, available for prescription, or appropriate for an individual patient.
Your provider will determine what treatment options, if any, are medically appropriate.
Your provider may recommend laboratory testing as part of your evaluation. The specific testing depends on your individual health needs and the treatment being considered.
Depending on your individual needs and clinical evaluation, treatment may be incorporated into a broader personalized health plan that can include nutrition, lifestyle recommendations, hormone care, weight management, or other appropriate services.
The first step is a consultation with a BiogenesisRx provider. Together, you'll discuss your goals, review your health history, and determine whether a peptide-based treatment or another approach may be appropriate for you.
Peptide availability is state-specific and product-specific.

Available Now
Available Soon
Some peptide therapies restricted
Most of our peptides are available in the following covered states:
Alaska
Alabama
Arkansas
Arizona
California
Colorado
Connecticut
District of Columbia
Delaware
Florida
Georgia
Hawaii
Iowa
Idaho
Illinois
Indiana
Kansas
Kentucky
Massachusetts
Maryland
Maine
Michigan
Minnesota
Mississippi
Montana
North Carolina
Nebraska
New Hampshire
New Mexico
Nevada
Ohio
Oklahoma
Oregon
Pennsylvania
South Carolina
Tennessee
Texas
Utah
Virginia
Vermont
Washington
Wisconsin
West Virginia
Wyoming
+ Certain peptide therapies are restricted in some states under current regulations. Other non-restricted therapies may remain available.
California, Ohio, and Nevada residents currently have access to Weight Loss peptides only.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Peptide availability is state-specific and product-specific.

Available Now
Available Soon
Some peptide therapies restricted
Most of our peptides are available in the following covered states:
Alaska
Alabama
Arkansas
Arizona
California
Colorado
Connecticut
District of Columbia
Delaware
Florida
Georgia
Hawaii
Iowa
Idaho
Illinois
Indiana
Kansas
Kentucky
Massachusetts
Maryland
Maine
Michigan
Minnesota
Mississippi
Montana
North Carolina
Nebraska
New Hampshire
New Mexico
Nevada
Ohio
Oklahoma
Oregon
Pennsylvania
South Carolina
Tennessee
Texas
Utah
Virginia
Vermont
Washington
Wisconsin
West Virginia
Wyoming
+ Certain peptide therapies are restricted in some states under current regulations. Other non-restricted therapies may remain available.
California, Ohio, and Nevada residents currently have access to Weight Loss peptides only.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Peptide availability is state-specific and product-specific.

Available Now
Available Soon
Some peptide therapies restricted
Most of our peptides are available in the following covered states:
Alaska
Alabama
Arkansas
Arizona
California
Colorado
Connecticut
District of Columbia
Delaware
Florida
Georgia
Hawaii
Iowa
Idaho
Illinois
Indiana
Kansas
Kentucky
Massachusetts
Maryland
Maine
Michigan
Minnesota
Mississippi
Montana
North Carolina
Nebraska
New Hampshire
New Mexico
Nevada
Ohio
Oklahoma
Oregon
Pennsylvania
South Carolina
Tennessee
Texas
Utah
Virginia
Vermont
Washington
Wisconsin
West Virginia
Wyoming
+ Certain peptide therapies are restricted in some states under current regulations. Other non-restricted therapies may remain available.
California, Ohio, and Nevada residents currently have access to Weight Loss peptides only.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.



Stay up to date with the latest health and wellness insights from BiogenesisRx.
© 2026 BiogenesisRx. All Rights Reserved. | Privacy Policy | Terms of Service
The information provided on the BiogenesisRx website and social media channels is for educational and informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Nothing on this website should be interpreted as medical advice or as establishing a provider-patient relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition or treatment decisions. If you believe you are experiencing a medical emergency, call 911 or your local emergency services immediately.
Some therapies or services offered by BiogenesisRx may not be approved by the U.S. Food and Drug Administration (FDA) for every intended use and may be prescribed or recommended by licensed healthcare providers based on their independent professional judgment and applicable laws. Certain therapies, including compounded medications or off-label treatments, may not be FDA approved for specific uses. Treatment recommendations are made only after an individualized medical evaluation and when deemed clinically appropriate by a licensed healthcare provider.
Individual results vary. BiogenesisRx does not guarantee specific outcomes, symptom improvement, weight loss, longevity benefits, or any other medical results. Every treatment plan is personalized based on your medical history, symptoms, laboratory findings, and clinical evaluation.
By using this website, you acknowledge and agree that any decisions regarding your healthcare should be made in consultation with a licensed healthcare provider. Your use of this website constitutes acceptance of our Privacy Policy and Terms of Service.
Prescription medications, including compounded therapies when appropriate, are available only following a medical evaluation by a licensed healthcare provider and in accordance with applicable federal and state laws.



About Us
Stay up to date with the latest health and wellness insights from BiogenesisRx.
© 2026 BiogenesisRx. All Rights Reserved. | Privacy Policy | Terms of Service
The information provided on the BiogenesisRx website and social media channels is for educational and informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Nothing on this website should be interpreted as medical advice or as establishing a provider-patient relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition or treatment decisions. If you believe you are experiencing a medical emergency, call 911 or your local emergency services immediately.
Some therapies or services offered by BiogenesisRx may not be approved by the U.S. Food and Drug Administration (FDA) for every intended use and may be prescribed or recommended by licensed healthcare providers based on their independent professional judgment and applicable laws. Certain therapies, including compounded medications or off-label treatments, may not be FDA approved for specific uses. Treatment recommendations are made only after an individualized medical evaluation and when deemed clinically appropriate by a licensed healthcare provider.
Individual results vary. BiogenesisRx does not guarantee specific outcomes, symptom improvement, weight loss, longevity benefits, or any other medical results. Every treatment plan is personalized based on your medical history, symptoms, laboratory findings, and clinical evaluation.
By using this website, you acknowledge and agree that any decisions regarding your healthcare should be made in consultation with a licensed healthcare provider. Your use of this website constitutes acceptance of our Privacy Policy and Terms of Service.
Prescription medications, including compounded therapies when appropriate, are available only following a medical evaluation by a licensed healthcare provider and in accordance with applicable federal and state laws.



Peptides
Weight Loss
Hormone Replacement Therapy
Genetic Testing
About Us
Blog
Testimonials
Where We Serve
Contact Us
FAQs
Privacy Policy
Terms of Service
Stay up to date with the latest health and wellness insights from BiogenesisRx.
© 2026 BiogenesisRx. All Rights Reserved. | Privacy Policy | Terms of Service
The information provided on the BiogenesisRx website and social media channels is for educational and informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Nothing on this website should be interpreted as medical advice or as establishing a provider-patient relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition or treatment decisions. If you believe you are experiencing a medical emergency, call 911 or your local emergency services immediately.
Some therapies or services offered by BiogenesisRx may not be approved by the U.S. Food and Drug Administration (FDA) for every intended use and may be prescribed or recommended by licensed healthcare providers based on their independent professional judgment and applicable laws. Certain therapies, including compounded medications or off-label treatments, may not be FDA approved for specific uses. Treatment recommendations are made only after an individualized medical evaluation and when deemed clinically appropriate by a licensed healthcare provider.
Individual results vary. BiogenesisRx does not guarantee specific outcomes, symptom improvement, weight loss, longevity benefits, or any other medical results. Every treatment plan is personalized based on your medical history, symptoms, laboratory findings, and clinical evaluation.
By using this website, you acknowledge and agree that any decisions regarding your healthcare should be made in consultation with a licensed healthcare provider. Your use of this website constitutes acceptance of our Privacy Policy and Terms of Service.
Prescription medications, including compounded therapies when appropriate, are available only following a medical evaluation by a licensed healthcare provider and in accordance with applicable federal and state laws.